Welcome to our dedicated page for Barrick Mining news (Ticker: B), a resource for investors and traders seeking the latest updates and insights on Barrick Mining stock.
Barrick Mining Corporation reports developments tied to its global gold and copper mining, exploration and development portfolio. Company news commonly covers operating and financial results, mine and project updates, technical and governance matters, and capital allocation actions for common shares that trade on the NYSE under B and on the TSX under ABX.
Recurring updates include quarterly results releases, dividend declarations, share repurchase authorizations, annual meeting materials and changes in executive or board oversight. Barrick also reports on its gold assets in North America and other mining jurisdictions, including disclosures connected to major mines, development projects, reserves, production, costs, cash flow and responsible mining obligations.
BioArctic (Nasdaq Stockholm: BIOA B) announced that partner Eisai projects Leqembi sales of JPY 143.5 billion (about SEK 8.4 billion) for FY 2026 (April 2026–March 2027), a 63% increase year over year.
This is expected to generate roughly SEK 880 million in royalties to BioArctic. The companies are preparing joint commercialization of Leqembi for Alzheimer's disease in the Nordic region.
The Board of Directors of Crawford & Company (NYSE: CRD-A, CRD-B) approved a quarterly cash dividend of $0.075 per share on both Class A and Class B common stock. The dividend will be paid on June 12, 2026 to shareholders of record on May 29, 2026.
Barrick Mining (NYSE:B) reported voting results from its 2026 annual shareholder meeting. All nine board nominees were elected, with votes for ranging from 81.1% to 99.63%. Shareholders also approved the appointment of the auditor with 93.27% support and passed the advisory resolution on executive compensation with 76.66% support.
Barrick Mining (NYSE:B) is highlighted within a sector-wide reset in gold valuations, as senior producers report realized prices near $4,800–$4,900/oz and record cash flows.
Barrick posted record Q4 2025 operating cash flow of $2.73B, free cash flow of $1.62B, EPS of $1.43, and plans a late‑2026 IPO of a North American gold NewCo. Greenland Mines’ Skaergaard sensitivity study shows higher palladium‑equivalent grades at elevated gold price decks, though these are illustrative and not new reserves or economic estimates.
BioArctic (NASDAQ Stockholm: BIOA B) will publish its first quarter 2026 report for January–March on May 20, 2026 at 8:00 a.m. CET. A webcast and teleconference in English with the CEO and CFO will follow at 9:30 a.m. CET, including a Q&A session.
The webcast requires online registration for written questions, while verbal questions are handled via a separate teleconference registration. A replay will be available on BioArctic's investor website after the presentation.
Octave Intelligence (Ticker: B) will be distributed to Hexagon shareholders, with all Octave shares spun off as Swedish depository receipts (SDRs) or class B ordinary shares.
SDRs are expected to start trading on Nasdaq Stockholm on 25 May 2026 and Octave class B shares on Nasdaq New York via when-issued trading from 21 May 2026 and regular-way trading from 28 May 2026. The record date for the distribution is 22 May 2026, and each SDR represents one class B share.
Barrick (NYSE:B) reported strong Q1 2026 results, with gold production of 719,000 oz beating guidance of 640,000–680,000 oz and copper output of 49,000 tonnes. Revenue rose to $5.22 billion, net EPS to $0.96, and adjusted EPS to $0.98.
Operating cash flow reached $2.55 billion and attributable free cash flow $1.21 billion. Barrick maintained 2026 production and cost guidance, advanced the Lumwana expansion and Fourmile project, declared a $0.175 quarterly dividend, and authorized a new $3.0 billion share buyback while progressing a planned North American Barrick IPO.
Barrick Mining (NYSE:B) authorized a share repurchase of up to $3.0 billion of outstanding common shares at prevailing market prices.
The board aims to return cash to shareholders after strong free cash flow and sees exceptional value ahead of the planned IPO of North American Barrick.
Barrick Mining (NYSE:B) declared a $0.175 per share dividend for Q1 2026. The dividend will be paid on June 15, 2026 to shareholders of record on May 29, 2026.
Barrick targets an annual total dividend payout of 50% of attributable free cash flow, combining a fixed quarterly base with a year-end performance top-up, adjustable for cash flow strength and capital needs.
BioArctic (NYSE:B) reports that the FDA extended the PDUFA date for the sBLA for Leqembi Iqlik to August 24, 2026 after requesting additional information, which the agency classified as a major amendment and added a three‑month review period. The FDA has not raised approvability concerns to date.
Leqembi maintenance subcutaneous dosing received FDA action on August 26, 2025, and Leqembi is approved by more than 50 regulatory authorities worldwide. BioArctic and Eisai continue plans for joint Nordic commercialization.